Regulation And Legal
Cipla Receives 7 USFDA Observations at Pithampur Facility
Cipla discloses USFDA inspection results with 7 observations at its Pithampur facility following a cGMP audit.
The inspection occurred from August 17 to 25, 2026, as a follow-up to previous inspection